Trader consensus on Polymarket implies a 75.5% probability that the Centers for Disease Control and Prevention (CDC) will issue a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips due to high outbreak risk—for any disease by December 31, 2026. This sentiment stems from the early May hantavirus (Andes virus) cluster aboard the MV Hondius cruise ship in the South Atlantic, where at least three passenger deaths prompted CDC Emergency Operations Center activation at Level 3 for monitoring U.S. cases, amid genomic sequencing and repatriation efforts. No Level 3 notices are active per the CDC's May 7 update, but persistent Level 2 alerts for clade II mpox in Ghana and Liberia, meningococcal disease in the Democratic Republic of the Congo, and H5N1 avian influenza reservoirs in wild birds elevate escalation risks, with seasonal upticks in mosquito-borne illnesses like chikungunya as key variables. Upcoming CDC FluView reports and WHO surveillance briefings could shift trajectories.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-updateCDC issues Level 3 warning by December 31?
CDC issues Level 3 warning by December 31?
$117,038 Vol.
$117,038 Vol.
Dec 31, 2026
$117,038 Vol.
$117,038 Vol.
Dec 31, 2026
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus on Polymarket implies a 75.5% probability that the Centers for Disease Control and Prevention (CDC) will issue a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips due to high outbreak risk—for any disease by December 31, 2026. This sentiment stems from the early May hantavirus (Andes virus) cluster aboard the MV Hondius cruise ship in the South Atlantic, where at least three passenger deaths prompted CDC Emergency Operations Center activation at Level 3 for monitoring U.S. cases, amid genomic sequencing and repatriation efforts. No Level 3 notices are active per the CDC's May 7 update, but persistent Level 2 alerts for clade II mpox in Ghana and Liberia, meningococcal disease in the Democratic Republic of the Congo, and H5N1 avian influenza reservoirs in wild birds elevate escalation risks, with seasonal upticks in mosquito-borne illnesses like chikungunya as key variables. Upcoming CDC FluView reports and WHO surveillance briefings could shift trajectories.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Binuksan ang Market: Jan 19, 2026, 3:15 PM ET
Volume
$117,038Petsa ng Pagtatapos
Dec 31, 2026Binuksan ang Market
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus on Polymarket implies a 75.5% probability that the Centers for Disease Control and Prevention (CDC) will issue a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips due to high outbreak risk—for any disease by December 31, 2026. This sentiment stems from the early May hantavirus (Andes virus) cluster aboard the MV Hondius cruise ship in the South Atlantic, where at least three passenger deaths prompted CDC Emergency Operations Center activation at Level 3 for monitoring U.S. cases, amid genomic sequencing and repatriation efforts. No Level 3 notices are active per the CDC's May 7 update, but persistent Level 2 alerts for clade II mpox in Ghana and Liberia, meningococcal disease in the Democratic Republic of the Congo, and H5N1 avian influenza reservoirs in wild birds elevate escalation risks, with seasonal upticks in mosquito-borne illnesses like chikungunya as key variables. Upcoming CDC FluView reports and WHO surveillance briefings could shift trajectories.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Volume
$117,038Petsa ng Pagtatapos
Dec 31, 2026Binuksan ang Market
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus on Polymarket implies a 75.5% probability that the Centers for Disease Control and Prevention (CDC) will issue a Level 3 Travel Health Notice—recommending travelers reconsider nonessential trips due to high outbreak risk—for any disease by December 31, 2026. This sentiment stems from the early May hantavirus (Andes virus) cluster aboard the MV Hondius cruise ship in the South Atlantic, where at least three passenger deaths prompted CDC Emergency Operations Center activation at Level 3 for monitoring U.S. cases, amid genomic sequencing and repatriation efforts. No Level 3 notices are active per the CDC's May 7 update, but persistent Level 2 alerts for clade II mpox in Ghana and Liberia, meningococcal disease in the Democratic Republic of the Congo, and H5N1 avian influenza reservoirs in wild birds elevate escalation risks, with seasonal upticks in mosquito-borne illnesses like chikungunya as key variables. Upcoming CDC FluView reports and WHO surveillance briefings could shift trajectories.
Eksperimental na AI-generated summary na nire-reference ang Polymarket data. Hindi ito trading advice at wala itong papel sa kung paano nire-resolve ang market na ito. · Na-update
Mag-ingat sa mga external link.
Mag-ingat sa mga external link.
Mga Madalas na Tanong